References
Khanna R, Wilson SM, Brittain JM, Weimer J, Sultana R, Butterfield A et al. Future Neurol 2012; 7: 749–771.
Quach TT, Honnorat J, Kolattukudy PE, Khanna R, Duchemin AM. Mol Psychiatry 2015; 20: 1037–1045.
Bader V, Tomppo L, Trossbach SV, Bradshaw NJ, Prikulis I, Leliveld SR et al. Hum Mol Genet 2012; 21: 4406–4418.
Yamashita N, Takahashi A, Takao K, Yamamoto T, Kolattukudy P, Miyakawa T et al. Front Behav Neurosci 2013; 7: 216.
Tabares-Seisdedos R, Rubenstein JL. Mol Psychiatry 2009; 14: 563–589.
Rubinstein M, Patowary A, Stanaway IB, McCord E, Nesbitt RR, Archer M et al. Mol Psychiatry 2016; doi: 10.1038/mp.2016.222 (e-pub ahead of print 13 December 2016).
Nakata K, Ujike H, Sakai A, Takaki M, Imamura T, Tanaka Y et al. Biol Psychiatry 2003; 53: 571–576.
Fallin MD, Lasseter VK, Avramopoulos D, Nicodemus KK, Wolyniec PS, McGrath JA et al. Am J Hum Genet 2005; 77: 918–936.
Liu F, Laguesse S, Legastelois R, Morisot N, Ben Hamida S, Ron D. Mol Psychiatry 2017; 22: 89–101.
Taylor A, Wang KS. J Neural Transm 2014; 121: 105–111.
Zhang H, Kang E, Wang Y, Yang C, Yu H, Wang Q et al. Nat Commun 2016; 7; doi: 10.1038/ncomms11773.
Braunschweig D, Krakowiak P, Duncanson P, Boyce R, Hansen RL, Ashwood P et al. Transl Psychiatry 2013; 3: e277.
Quach TT, Massicotte G, Belin MF, Honnorat J, Glasper ER, Devries AC et al. FASEB J 2008; 22: 401–409.
Tsutiya A, Nishihara M, Goshima Y, Ohtani-Kaneko R. Eur J Neurosci 2015; 42: 2335–2345.
Yamashita N, Mosinger B, Roy A, Miyazaki M, Ugajin K, Nakamura F et al. J Neurosci 2011; 31: 1773–1779.
Brittain JM, Duarte DB, Wilson SM, Zhu W, Ballard C, Johnson PL et al. Nat Med 2011; 17: 822–829.
Moutal A, Chew LA, Yang X, Wang Y, Yeon SK, Telemi E et al. Pain 2016; 157: 1448–1463.
Laedermann CJ, Cachemaille M, Kirschmann G, Pertin M, Gosselin RD, Chang I et al. J Clin Invest 2013; 123: 3002–3013.
Dib-Hajj SD, Yang Y, Black JA, Waxman SG. Nat Rev Neurosci 2013; 14: 49–62.
Laedermann CJ, Syam N, Pertin M, Decosterd I, Abriel H. Front Cell Neurosci 2013; 7: 137.
Dustrude ET, Moutal A, Yang X, Wang Y, Khanna M, Khanna R. Proc Natl Acad Sci USA 2016; 113: E8443–E8452.
Dustrude ET, Wilson SM, Ju W, Xiao Y, Khanna R. J Biol Chem 2013; 288: 24316–24331.
Kamiya Y, Saeki K, Takiguchi M, Funakoshi K. Eur J Anaesthesiol 2013; 30: 214–214.
Balastik M, Zhou XZ, Alberich-Jorda M, Weissova R, Ziak J, Pazyra-Murphy MF et al. Cell Rep 2015; 13: 812–828.
Fischer G, Pan B, Vilceanu D, Hogan QH, Yu H. Gene Ther 2014; 21: 44–51.
Petratos S, Ozturk E, Azari MF, Kenny R, Young LJ, Magee KA et al. Brain 2012; 135(Pt 6): 1794–1818.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Moutal, A., Dustrude, E.T., Largent-Milnes, T.M. et al. Blocking CRMP2 SUMOylation reverses neuropathic pain. Mol Psychiatry 23, 2119–2121 (2018). https://doi.org/10.1038/mp.2017.117
Published:
Issue Date:
DOI: https://doi.org/10.1038/mp.2017.117
- Springer Nature Limited
This article is cited by
-
Pathology of pain and its implications for therapeutic interventions
Signal Transduction and Targeted Therapy (2024)
-
Non-SUMOylated CRMP2 decreases NaV1.7 currents via the endocytic proteins Numb, Nedd4-2 and Eps15
Molecular Brain (2021)
-
DNMT3b SUMOylation Mediated MMP-2 Upregulation Contribute to Paclitaxel Induced Neuropathic Pain
Neurochemical Research (2021)
-
Downregulation of hippocampal SIRT6 activates AKT/CRMP2 signaling and ameliorates chronic stress-induced depression-like behavior in mice
Acta Pharmacologica Sinica (2020)
-
Dynamic CRMP2 Regulation of CaV2.2 in the Prefrontal Cortex Contributes to the Reinstatement of Cocaine Seeking
Molecular Neurobiology (2020)